China · Delayed Price · Currency is CNY PharmaBlock Sciences (Nanjing) Company Description
PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally.
It offers medicinal chemistry-oriented SAR/SPR tool kits for molecule design; building blocks enabled libraries, including fragment-based drug discovery, DNA encoded library technology, and mega virtual library screening to support the discovery of novel hit compounds; custom synthesis (FFS); and full time equivalent (FTE).
The company also provides small molecule drug substance CDMO services, including optimal route scouting; FFS and FTE for process research and development of RSMs, intermediates, and APIs; impurity studies and synthesis; solid state chemistry; analytical development and quality control; cGMP manufacturing of intermediates and APIs; and CMC regulatory filing support.
In addition, it offers small molecule DP CDMO services, such as candidate screening and selection, early development, full development, registration, and post-approval; and new modality services, including target protein degrader, peptide, oligonucleotide, and ADC services.
PharmaBlock Sciences (Nanjing), Inc. was founded in 2006 and is based in Nanjing, the People's Republic of China.
| Country | China |
| Founded | 2006 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,455 |
| CEO | Minmin Yang |
Contact Details
Address: No. 81, Huasheng Road Nanjing, 210032 China | |
| Phone | 86 25 8691 8218 |
| Website | pharmablock.com |
Stock Details
| Ticker Symbol | 300725 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000035K5 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Dr. Minmin Yang Ph.D. | Co-Founder, Chairman and Chief Executive Officer |
| Dr. Shijie Zhang Ph.D. | Chief Technology Officer |
| Zhiho Ng Chen | Executive Vice President |
| Dr. Jing Li Ph.D. | Senior Vice President of Process Chemistry and President of PharmaBlock (USA), Inc. |
| Shanbao Yu | Secretary of the Board |
| Dr. Shuhai Zhao Ph.D. | Co-founder and Chief Scientific Officer |
| Dr. David Chen Ph.D. | Executive Vice President, Chief Operation Officer and Head of CDMO |
| Dr. Dezhi Sha Ph.D. | Senior Vice President of Process Technology and Manufacturing |